Status:
COMPLETED
Intra-articular Corticosteroid Injection Compared With Single-Shot Hyaluronic Acid for Treatment of Osteoarthritis Knee
Lead Sponsor:
Thammasat University
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
40-80 years
Phase:
PHASE4
Brief Summary
Corticosteroid and Hylan G-F 20 are both effective in improving pain and function of osteoarthritic knee patients.
Detailed Description
Corticosteroid and Hylan G-F 20 are both effective in improving pain and function of osteoarthritic knee patients up to 6 months.
Eligibility Criteria
Inclusion
- Clinical diagnosis of knee OA
- Knee pain for most days of the prior month
- Radiographic evidence consistent with knee OA
- Aged between 40 and 80 years old
Exclusion
- Lumbar spondylosis
- Gross deformity of the knee
- Co-existent inflammatory or crystal arthritis
- Prior knee surgery
- Injury to the knee in the preceding 6 months
- Any intra-articular injection in the preceding 3 months
- Pregnant or Lactating
- Current infection in the affected knee
- Inability to provide informed consent
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01874574
Start Date
January 1 2011
End Date
September 1 2013
Last Update
April 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thammasat University Hospital, Thammasat University
Prathumthani, Changwat Pathum Thani, Thailand, 12121